ArticleClinical and translational medicine2023

CD19/CD22 dual-targeting chimeric antigen receptor T-cell therapy bridging to allogeneic haematopoietic stem cell transplantation for B-cell acute lymphoblastic leukaemia delays platelet recovery and increases risks of cytomegalovirus and Epstein-Barr virus viremia after transplantation.

Shijia Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.